The 5-Alpha Reductase Inhibitor Finasteride Reduces Dyskinesia in a Rat Model of Parkinson’s Disease

    January 2017 in “ Experimental Neurology
    Roberto Frau, Paola Savoia, Silvia Fanni, Chiara Fiorentini, Camino Fidalgo, Elisabetta Tronci, Roberto Stancampiano, Mario Meloni, Antonino Cannas, Francesco Marrosu, Marco Bortolato, Paola Devoto, Cristina Missale, Manolo Carta
    Image of study
    TLDR Finasteride reduces movement issues in Parkinson's disease rats.
    The study investigated the effects of the 5-alpha reductase inhibitor finasteride on dyskinesia in a rat model of Parkinson's disease. The results showed that chronic administration of finasteride reduced L-DOPA-induced dyskinesias in the rats. The antidyskinetic effect of finasteride may be exerted via modulation of both the D₁- and D₂/D3 receptor pathways. The study suggests that finasteride may have potential as a treatment for dyskinesia in Parkinson's disease patients.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results